Relapses in Anti-NMDAR Encephalitis

Relapses of anti-NMDAR encephalitis are uncommon, mostly monosymptomatic, and less severe than the first episode. At onset, presenting CSF pleocytosis or an underlying tumor decreases the risk of relapses. In addition, the early administration of first-line and second-line immunotherapies, particularly rituximab, could protect against further relapses.

Authors

Institutions

Publication Details

Journal
Neurology Neuroimmunology & Neuroinflammation
Published
2025-06-18
DOI
https://doi.org/10.1212/nxi.0000000000200421
Citations
5
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
6.95
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Relapses in Anti-NMDAR Encephalitis

Antonio Farina, David Gonçalves, Pedro Jesús Serrano-Castro, Mélodie Aubart et al.
5 citations
Neurology Neuroimmunology & Neuroinflammation
Autoimmune Neurological Disorders and Treatments
6.95
article

Relapses in Anti-NMDAR Encephalitis

Antonio Farina, David Gonçalves, Pedro Jesús Serrano-Castro, Mélodie Aubart, Géraldine Picard, Begoña Oliver‐Martos, Alberto Vogrig, Dimitri Psimaras, Nicolás Lundahl Ciano-Petersen, Macarena Villagrán‐García, Véronique Rogemond, Jérôme Honnorat, Sergio Muñiz‐Castrillo, Bastien Joubert, Nicole Fabien
article en
5 citations

Abstract

Relapses of anti-NMDAR encephalitis are uncommon, mostly monosymptomatic, and less severe than the first episode. At onset, presenting CSF pleocytosis or an underlying tumor decreases the risk of relapses. In addition, the early administration of first-line and second-line immunotherapies, particularly rituximab, could protect against further relapses.

Neurology Neuroimmunology & NeuroinflammationVol. 12(4)
Université Claude Bernard Lyon 1 (FR), Hôpital Necker-Enfants Malades (FR), University of Udine (IT), Centre National de la Recherche Scientifique (FR), Inserm (FR), Université Paris Cité (FR), Sorbonne Université (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospices Civils de Lyon (FR), Hospital Universitario 12 De Octubre (ES), Hospital Regional Universitario de Málaga (ES), Ospedale Santa Maria della Misericordia di Udine (IT), Instituto de Investigación Biomédica de Málaga (ES), Institut des Maladies Génétiques Imagine (FR), Universidad de Málaga (ES)
Good health and well-being
Openalex Percentile: Top 3%
Autoimmune Neurological Disorders and Treatments
6.95
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.